Works matching DE "INTERPLEURAL drug administration"
Results: 10
Intrapleural tissue plasminogen activator and deoxyribonuclease administered concurrently and once daily for complex parapneumonic pleural effusion and empyema.
- Published in:
- Internal Medicine Journal, 2023, v. 53, n. 12, p. 2313, doi. 10.1111/imj.16084
- By:
- Publication type:
- Article
Effectiveness of Intrapleural Tissue Plasminogen Activator and Dornase Alfa vs Tissue Plasminogen Activator Alone in Children with Pleural Empyema: A Randomized Clinical Trial.
- Published in:
- JAMA Pediatrics, 2020, v. 174, n. 4, p. 332, doi. 10.1001/jamapediatrics.2019.5863
- By:
- Publication type:
- Article
Addition of Dornase to Intrapleural Fibrinolytic Therapy Is Not Superior to Fibrinolytic Therapy Alone for Otherwise Healthy Children Hospitalized With Empyema.
- Published in:
- 2020
- By:
- Publication type:
- Opinion
Incidence of malignant mesothelioma of the pleura in Québec and Canada from 1984 to 2007, and projections from 2008 to 2032.
- Published in:
- American Journal of Industrial Medicine, 2015, v. 58, n. 5, p. 473, doi. 10.1002/ajim.22442
- By:
- Publication type:
- Article
Effects of oxytocin on methamphetamine-seeking exacerbated by predator odor pre-exposure in rats.
- Published in:
- Psychopharmacology, 2016, v. 233, n. 6, p. 1015, doi. 10.1007/s00213-015-4184-7
- By:
- Publication type:
- Article
Therapeutical Effects of Pleural Injecting Recombinant Human Endostain to Malignant Pleural Effusion Nude Mice Model.
- Published in:
- Chinese Journal of Lung Cancer, 2015, v. 18, n. 5, p. 266, doi. 10.3779/j.issn.1009-3419.2015.05.03
- By:
- Publication type:
- Article
Prognostic impact of a new score using neutrophil-to-lymphocyte ratios in the serum and malignant pleural effusion in lung cancer patients.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Pharmacokinetic profile of paclitaxel in the plasma, lung, and diaphragm following intravenous or intrapleural administration in rats.
- Published in:
- Thoracic Cancer, 2015, v. 6, n. 1, p. 43, doi. 10.1111/1759-7714.12139
- By:
- Publication type:
- Article
Intratumoral Treatment in Lung Cancer: Is It Time to Move Towards Clinical Practice?
- Published in:
- Cancers, 2024, v. 16, n. 23, p. 3892, doi. 10.3390/cancers16233892
- By:
- Publication type:
- Article
The NLRP3 inflammasome in pathogenic particle and fibre-associated lung inflammation and diseases.
- Published in:
- Particle & Fibre Toxicology, 2016, p. 1, doi. 10.1186/s12989-016-0162-4
- By:
- Publication type:
- Article